What is Baqsimi nasal powder?
Baqsimi is a new portable, dry nasal spray of powdered glucagon developed by Eli Lilly pharmaceuticals. This is a ready to use form of glucagon that doesn’t require any mixing before use. It was the first FDA approved powder version of glucagon which can help to increase blood glucose levels in people who are having a hypoglycemic event.
Each packet contains 2 cartridges for use in the management of severe hypoglycemia when a person requires the help of another person.
Baqsimi doesn’t need to be refrigerated and can be stored in temperatures up to 30 degrees Celsius (86 degrees Fahrenheit). Baqsimi can also be used in people with diabetes from four years and older.
When should Baqsimi glucagon be used?
Baqsimi glucagon is designed to be used as an emergency measure for the treatment of hypoglycemia (low blood sugar level) when a person with diabetes is unable to help themselves or eat sugar containing foods safely.
At what age can Baqsimi glucagon be used?
Baqsimi glucagon has been approved to be used in adults and children aged 4 and older. It is likely further studies will examine the safety in children under 4 years in the future.
How is Baqsimi nasal powder used?
Baqsimi comes in a single 3mg dose which is absorbed in the nose. It does not need to be inhaled. Baqsimi is a powder which is administered into the nose of someone having a hypoglycemic event from a single-use dispenser.